company background image
A214150 logo

CLASSYS KOSDAQ:A214150 Stock Report

Last Price

₩49.55k

Market Cap

₩3.2t

7D

-5.3%

1Y

58.1%

Updated

15 Jul, 2024

Data

Company Financials +

A214150 Stock Overview

Provides medical aesthetics devices worldwide.

A214150 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance3/6
Financial Health6/6
Dividends0/6

CLASSYS Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CLASSYS
Historical stock prices
Current Share Price₩49,550.00
52 Week High₩56,900.00
52 Week Low₩27,850.00
Beta0.59
11 Month Change-5.80%
3 Month Change33.02%
1 Year Change58.05%
33 Year Change140.53%
5 Year Change287.11%
Change since IPO973.67%

Recent News & Updates

We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt

Jun 08
We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt

CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors

May 21
CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors

Recent updates

We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt

Jun 08
We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt

CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors

May 21
CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors

Capital Investment Trends At CLASSYS (KOSDAQ:214150) Look Strong

Apr 24
Capital Investment Trends At CLASSYS (KOSDAQ:214150) Look Strong

Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock

Apr 09
Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock

When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?

Mar 09
When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?

Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 17
Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate

Feb 02
CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate

The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested

Jan 17
The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested

Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today

Jan 04
Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today

The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?

Dec 22
The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?

Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?

Dec 09
Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?

What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?

Nov 26
What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?

Shareholder Returns

A214150KR Medical EquipmentKR Market
7D-5.3%-3.9%-0.2%
1Y58.1%23.0%6.5%

Return vs Industry: A214150 exceeded the KR Medical Equipment industry which returned 23% over the past year.

Return vs Market: A214150 exceeded the KR Market which returned 6.5% over the past year.

Price Volatility

Is A214150's price volatile compared to industry and market?
A214150 volatility
A214150 Average Weekly Movement8.6%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.9%
10% most volatile stocks in KR Market11.2%
10% least volatile stocks in KR Market2.3%

Stable Share Price: A214150's share price has been volatile over the past 3 months.

Volatility Over Time: A214150's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2007353n/aclassys.co.kr

CLASSYS Inc. provides medical aesthetics devices worldwide. Its products include SCIZER for non-invasive subcutaneous fat reduction; ULTRAFORMER MPT, a solution for eyebrow lifting by coagulating skin tissue with a focused ultrasound stimulation system; ULTRAFORMER III, a high-intensity focused ultrasound surgical device used for tissue coagulation in eyelid lifting for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs, as well as for addressing crow's feet, laugh lines, and neck wrinkles; INTRASURE, an aesthetics and healthcare multi-platform solution; FORSHAPE, an RF treatment system to increase metabolism, blood circulation, and tissue recovery; and VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue as a general electrosurgical instrument. It also provides CLATUU Alpha, a medical device that gradually reduces subcutaneous fat layers, particularly in areas with excessive fat accumulation, using low-temperature energy and negative pressure; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs by delivering HIFU energy; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE is the combination of four handpieces are respectively applied for acne suction, muscle pain relief, and other pain relief; and AQUAPURE II, a multi-functional facial and body care device.

CLASSYS Inc. Fundamentals Summary

How do CLASSYS's earnings and revenue compare to its market cap?
A214150 fundamental statistics
Market cap₩3.17t
Earnings (TTM)₩81.54b
Revenue (TTM)₩191.53b

38.9x

P/E Ratio

16.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A214150 income statement (TTM)
Revenue₩191.53b
Cost of Revenue₩41.40b
Gross Profit₩150.13b
Other Expenses₩68.59b
Earnings₩81.54b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.27k
Gross Margin78.38%
Net Profit Margin42.57%
Debt/Equity Ratio21.5%

How did A214150 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

16%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.